Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antihypertensive Mechanisms of Minocycline in Resistant Hypertension: Role of the Gut Microbiota-brain-immune Axis

NCT06246396 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT06246396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06246396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antihypertensive Mechanisms of Minocycline in Resistant Hypertension: Role of the Gut Microbiota-brain-immune Axis
Lead sponsor
University of Florida
Phase
Phase 4
Overall status
Recruiting
Start date
January 8, 2025
Completion date
July 31, 2028
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, resistant to conventional therapy